Live Breaking News & Updates on Rick Winningham

Stay updated with breaking news from Rick winningham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

DUBLIN, April 10, 2024 /PRNewswire/ Theravance Biopharma, Inc. today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio. ....

United States , Theravance Biopharma , Rhonda Farnum , Italo Biaggioni , Horacio Kaufmann , Feliciab Axelrod , Rick Winningham , Theravance Biopharma Inc , Dysautonomia Center , Vanderbilt Autonomic Dysfunction Center , York University Grossman School Of Medicine , Prnewswire Theravance Biopharma Inc , Neurological Institute , Division Of Autonomic Disorders , Langone Health , National Institute Of Neurological Disorders , Movement Disorders Society , Clinical Autonomic Research , New York University Grossman School , Pharmacology Director , Raine Miller , Chief Business Officer , Axelrod Professor , Autonomic Disorders , Pure Autonomic Failure , Natural History Study ,

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04. ....

City Of , United Kingdom , United States , Rick Winningham , Douglas Tsao , Theravance Biopharma , David Risinger , Rhonda Farnum , Aziz Sawaf , Head Of Development , Theravance Biopharma Inc , National Institutes Of Health , Department Of Neurosciences , Call Transcript February , Theravance Biopharma Fourth Quarter , Chief Executive , Raine Miller , Chief Business Officer , Chief Financial , Inflation Reduction , National Institutes , Gold Report , Best Paying Jobs , Best Job ,

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Rick Winningham , Boehringer Ingelheim Spiriva , Viatri Yupelri , South San Francisco , Boehringer Ingelheim ,

Theravance Biopharma: Phase 4 PIFR-2 Study Fails To Meet Primary Endpoint

Theravance Biopharma, Inc. (TBPH) announced results from the Phase 4 PIFR-2 study of YUPELRI inhalation solution, the nebulized long-acting muscarinic antagonist approved in the U. ....

Spiriva Handihaler , Rick Winningham , Theravance Biopharma Inc , More Such Health News , Theravance Biopharma , Chronic Obstructive Pulmonary Disease ,

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Third Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […] ....

Theravance Biopharma , Rick Winningham , Rhonda Farnum , Aziz Sawaf , Semiconductor Stocks To Buy , Gold Report , Semiconductor Stocks To Buy Now , Electric Utility Stocks To Buy , Dick Graham , Rick Winningham , Rhonda Farnum , Pet Sales ,